Human malignant glioma therapy using anti-α(V)β3 integrin agents

Journal of Neuro-Oncology

Volumn 46, Issue 2, 2000, Pages 135-144

  Chatterjee, Subhendra ^a   Matsumura, Akiko ^b   Schradermeier, Jaime ^a   Yancey Gillespie, G ^c  

^a JCR Biopharmaceuticals Inc   (United States)

^b JCR Pharmaceuticals Co Ltd   (Japan)

^c University of Alabama at Birmingham   (United States)

Author keywords

Apoptosis; cRGDfV; Human gliomas; Integrin (V) 3; Mouse glioma model

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; INTEGRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG BINDING; DRUG INHIBITION; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; TREATMENT OUTCOME;

ANIMALS; BRAIN NEOPLASMS; CASPASE 3; CASPASE 9; CASPASES; CELL DIVISION; CELL MEMBRANE; CELL SURVIVAL; ENZYME INHIBITORS; GLIOMA; HUMANS; INJECTIONS, INTRALESIONAL; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; OLIGOPEPTIDES; PEPTIDES, CYCLIC; RECEPTORS, VITRONECTIN; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 0034045074     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006444300504     Document Type: Article

References (36)

1. Cavenee WK, Bigner DD, Newcomb EW, Paulus W, Kleihues P: Diffuse astrocytomas. In: Kleihues P, Cavenee WK (eds). Pathology and Genetics of Tumours of the Nervous System. IARC Press, Lyon, France, 1997, pp 2-9
2. Mahaley MS, Jr, Mettlin C, Natarajan N, Laws ER, Peace BB: National survey of patterns of care for brain-tumor patients. J Neurosurg 71: 826-836, 1989
3. Walker MD, Green SB, Byar DP, Alexander E, Jr, Balzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Jr, Mealey J, Jr, Owens G, Ransohoff JI, Robertson JT, Shapiro WR, Smith KR, Jr, Wilson CB, Strike TA: Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303: 1323-1329, 1980
4. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164, 1994
5. 3 A for angiogenesis. Science 264: 569-571, 1994
6. 3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat Med 4: 408-414, 1998
7. v integrins. Science 270: 1500-1502, 1995
8. Chothia C, Jones EY: The molecular structure of cell adhesion molecules. Annu Rev Biochem 66: 823-862, 1997
9. Ruoslahti E: RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 12: 697-715, 1996
10. Felding-Habermann B, Cheresh DA: Vitronectin and its receptors. Curr Opin Cell Biol 5: 864-868, 1993
11. Chatterjee S, Bradac J, Hunter E: Effect of monensin on Mason-Pfizer monkey virus glycoprotein synthesis. J Virol 44: 1003-1012, 1982
12. Chambers R, Gillespie GY, Soroceanu L, Andreansky S, Chatterjee S, Chou J, Roizman B, Whitley RJ: Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci USA, 92: 1411-1415, 1995
13. Salvesen GS, Dixit VM: Caspases: intracellular signaling by proteolysis. Cell 91: 443-446, 1997
14. Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326: 1-16, 1997
15. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273: 9357-9360, 1998
16. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-1321, 1998
17. Sakahira H, Enari M, Nagata S: Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391: 96-99, 1998
18. 3 integrin: adhesion mechanism for transformed glial cells. J Clin Invest 88: 1924-1932, 1991
19. Gladson C, Wilcox JN, Sanders L, Gillespie GY, Cheresh DA: Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors. J Cell Science 108: 947-956, 1995
20. Wikstrand CJ, Bigner SH, Bigner DD: Demonstration of complex antigenic heterogenecity in a human glioma cell line and eight derived clones by specific monoclonal antibodies. Cancer Res 43: 3327-3334, 1983
21. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG: Specific proteolytic cleavage of poly (ADP-Ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 53: 3976-3985, 1993
22. Satoh MS, Lindahl T: Role of poly (ADP-Ribose) formation in DNA repair. Nature 356: 356-358, 1992
23. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90: 405-413, 1997
24. 3 during angiogenesis. J Clin Invest 98: 426-433, 1996
25. Gomez-Manzano C, Fueyo J, Kyritis AP, McDonnell TJ, Steck PA, Levin VA, Yung W: Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst 89: 1036-1044, 1997
26. Vuori K, Ruoslahti E: Association of insulin receptor substrate-1 with integrins. Science 266: 1576-1578, 1994
27. 3 integrin associates with activated insulin and PDGF-β receptors and potentiates the biological activity of PDGF. EMBO J 16: 5600-5607, 1997
28. Nister M, Clasesson-Welch L, Enksson A, Heldin CH, Westermark B: Differential expression of platelet-derived growth factor receptors in human malignant glioma cell lines. J Biol Chem 266: 16755-16763, 1991
29. Glick RP, Unterman TG, Hollis R: Radioimmunoassay of insulin-like growth factors in cyst fluid of central nervous system tumors. J Neurosurg 74: 972-978, 1991
30. Rubin R, Baserga R: Insulin-like growth factor-I receptor: its role in cell proliferation, apoptosis and tumorigenicity. Lab Invest 73: 311-331, 1995
31. Yang B-C, Chang H-M, Wang Y-S, Chen R-F, Lin S-J: Transient induction of apoptosis in serum-starved glioma cells by insulin and IGF-I. Biochim Biophys Acta 1314: 83-92, 1996
32. Burgaud JL, Resnicoff M, Baserga R: Mutant IGF-I receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun 214: 475-481, 1995
33. Resnicoff M, Li W, Basak S, Herlyn D, Baserga R, Rubin R: Inhibition of rat C6 glioblastoma tumor growth by expression of insulin-like growth factor I receptor anti-sense mRNA. Cancer Immunol Immunother 42: 64-68, 1996
34. Kulik G, Kippel A, Weber MJ: Antiapoptotic signaling by the insulin-like growth factor-I receptor, phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 17: 1595-1606, 1997
35. Saitoh Y, Kurastsu J, Takeshima H, Yamamoto S, Ushio Y: Expression of osteopontin in human gliomas: its correlation with malignancy. Lab Invest 72: 55-63, 1995
36. Tucker MA, Chang P, Prince CW, Gillespie GY, Mapstone TB: TPA-mediated regulation of osteopontin in human malignant glioma cells. Anticancer Res 18: 807-812, 1998